Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

The study introduced LIME-seq, a new non-invasive technique capable of detecting RNA modifications at a detailed level across ...

Tempus AI Inc. shares rose after it said it received 510 (k) clearance from the Food and Drug Administration for its RNA-based in vitro diagnostic device. Its stock recently rose 5.2% to $92.85 in ...

To solve a problem, scientists first need to see it clearly. Whether it’s a virus slipping past the immune system or plaques ...

RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical translation of diagnostic RNA-seq has not been widely achieved. Researchers at ...

Background Molecular genetic diagnoses are critical to prevention and treatment of inherited polyposis and colorectal cancer.

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 5% on Monday after the company announced it received 510 (k) clearance from the U.S. Food and Drug Administration for its RNA-based Tempus xR ...

Details: Two FFPE-derived DNA samples (colon and liver) alongside a high-quality genomic DNA control (NA12878) were used to ...

Through a comprehensive approach combining transcriptomic profiling, histological analysis, and functional validation in ...

Natural systems such as CRISPR-associated transposons (CASTs) offer a targetable, one-step way to edit genomes. However, ...

Autism-linked genes evolved rapidly in humans. They may have aided brain growth and language. A recent study published in Molecular Biology and Evolution by Oxford University Press suggests that the r ...

Plant scientists discovered hidden stem cell regulators tied to growth and crop size. Their breakthrough could transform how we grow food, fuel, and resilient harvests.